Thyroid carcinoma metastatic to the skin: A cutaneous manifestation of a widely disseminated malignancy - 11/09/11
Abstract |
Background: Cutaneous metastases develop in 2% to 9% of patients with an internal malignancy. Thyroid carcinoma metastatic to the skin is a rare clinical entity.
Objective: Our purpose was to study the clinical and pathologic features and outcome in patients with cutaneous metastasis from thyroid carcinoma.
Methods: The study included a retrospective analysis of six patients with skin metastases from thyroid carcinoma and a review of the English-language literature since 1964.
Results: Including our six patients, 43 patients with skin metastases from thyroid carcinoma have been reported. Papillary carcinoma was the most common (41%), followed by follicular (28%), anaplastic (15%), and medullary carcinomas (15%). The scalp was the most common site of metastasis. For our patients, the average length of survival after diagnosis of cutaneous metastasis was 19 months.
Conclusion: Cutaneous metastasis from thyroid carcinoma is rare and occurs in the setting of disseminated neoplastic disease. (J Am Acad Dermatol 1997;36:531-7.)
Le texte complet de cet article est disponible en PDF.Plan
From the Department of Dermatology,a Section of Surgical Pathology,b Division of Endocrinology/Metabolism and Internal Medicine,c Mayo Clinic and Mayo Foundation. |
|
Reprint requests: David G. Brodland, MD, Department of Dermatology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905. |
|
0190-9622/97/$5.00 + 0 16/1/78976 |
Vol 36 - N° 4
P. 531-537 - avril 1997 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?